Pitfalls of using the risk ratio in meta-analysis

Res Synth Methods. 2019 Sep;10(3):398-419. doi: 10.1002/jrsm.1347. Epub 2019 Apr 11.

Abstract

For meta-analysis of studies that report outcomes as binomial proportions, the most popular measure of effect is the odds ratio (OR), usually analyzed as log(OR). Many meta-analyses use the risk ratio (RR) and its logarithm because of its simpler interpretation. Although log(OR) and log(RR) are both unbounded, use of log(RR) must ensure that estimates are compatible with study-level event rates in the interval (0, 1). These complications pose a particular challenge for random-effects models, both in applications and in generating data for simulations. As background, we review the conventional random-effects model and then binomial generalized linear mixed models (GLMMs) with the logit link function, which do not have these complications. We then focus on log-binomial models and explore implications of using them; theoretical calculations and simulation show evidence of biases. The main competitors to the binomial GLMMs use the beta-binomial (BB) distribution, either in BB regression or by maximizing a BB likelihood; a simulation produces mixed results. Two examples and an examination of Cochrane meta-analyses that used RR suggest bias in the results from the conventional inverse-variance-weighted approach. Finally, we comment on other measures of effect that have range restrictions, including risk difference, and outline further research.

Keywords: beta-binomial model; log-binomial model; relative risk; response ratio; risk difference.

MeSH terms

  • Algorithms
  • Antidepressive Agents, Tricyclic / adverse effects*
  • Antidepressive Agents, Tricyclic / therapeutic use*
  • Computer Simulation
  • Depression / drug therapy*
  • Diuretics / therapeutic use
  • Female
  • Humans
  • Likelihood Functions
  • Linear Models
  • Meta-Analysis as Topic*
  • Odds Ratio
  • Pre-Eclampsia / drug therapy
  • Pregnancy
  • Regression Analysis
  • Risk Assessment / methods*
  • Risk*

Substances

  • Antidepressive Agents, Tricyclic
  • Diuretics